Clinical Professor, Head of the Department of Clinical Oncology, The University of Hong Kong, Shenzhen Hospital

Dr. LEE is currently the:

• Deputy Hospital Chief Executive, and Chief of Service (Clinical Oncology Center),
University of Hong Kong-Shenzhen Hospital;
• Director, Shenzhen Hospital Accreditation Research Center;
• ISQua Expert, International Society for Quality in Health Care
• Vice-President, Shenzhen–Hong Kong Medical Specialist Training Center;
• Coordinator of the UICC TNM Global Advisory Group;

Dr. LEE’s Previous Key Appointments include:

• Professor & Head of the Department of Clinical Oncology, University of Hong
Kong;
• Board of Director, Union for International Cancer Control (UICC);
• Vice president, Hong Kong College of Radiologists.
 
Her Research Field focused on Nasopharyngeal Cancer. She has received many International Honors.

Hospital Authority, Hong Kong

Dr Jeffrey Lai is a specialist in Emergency Medicine. He has been working in Accident and Emergency Departments for more than 20 years in Hong Kong. Jeffrey also holds a Master in Public Administration from the University of Hong Kong. He is currently working as Chief Manager of the Quality and Standards Department in the Hospital Authority. He has been leading his team to establish quality standards for HA hospitals, including credentialing, informed consent, waiting times for outpatient services and elective services. His office is also responsible to plan, organize and implement hospital accreditation for HA hospitals.

Director, Patient Safety and Quality Improvement, Ministry of Health, Singapore

Dr Albert Ty is the Director for Patient Safety and Quality Improvement in the Singapore Ministry of Health. He drives the development and implementation of national policies aimed at promoting a culture of patient safety, continuous quality improvement and value-based healthcare in Singapore healthcare institutions. This includes work on promoting High Reliability in healthcare, developing national regulations pertaining to patient safety and serious adverse events, and advancing the Ministry’s value-driven care enterprise. Prior to this, Dr Ty had extensive public health leadership experience in the Ministry including work on health promotion strategies, non-communicable disease epidemiology and control, public health intelligence, and specialist training and assessments.

Dr Ty is a neurologist/neuro-oncologist and a public health specialist by training. He holds a master’s degree in public health from the National University of Singapore and a master’s degree in health policy, planning and financing from the London School of Economics/London School of Hygiene and Tropical Medicine. Before joining the Ministry of Health, he had clinical and research stints at the National Neuroscience Institute, the National Cancer Centre, Singapore and the Singapore General Hospital.

Hong Kong Sanatorium Hospital, Hong Kong

Speaker bio coming soon.

Chief Executive Officer, Gleneagles Hospital Hong Kong and Regional Chief Executive Officer, IHH Healthcare North Asia; Hong Kong

Dr Kenneth Tsang provides leadership for Gleneagles Hospital Hong Kong, a multi-specialty tertiary hospital under an international healthcare group IHH Healthcare. Dr Tsang leads the hospital to provide excellent and innovative healthcare services in Hong Kong and at a regional level. Dr Tsang also steers the hospital’s development in the realms of digital health, clinical innovations and clinical research to foster its growth into a leading healthcare provider locally and regionally.

Dr Tsang joined Gleneagles Hospital Hong Kong in 2019 as Chief Operating Officer and was appointed as its Chief Executive Officer in 2021.

Dr Tsang was appointed as Regional Chief Executive Officer of IHH Healthcare North Asia in 2024. In conjunction with his role as Chairman of IHH China Operations Steering Committee, he plays a pivotal role in advancing IHH’s operations in China towards long-term growth. He also leads Parkway Medical Services (Hong Kong) Limited, a member of IHH Healthcare, which operates Gleneagles Healthcare ambulatory centres and clinics and Parkway Laboratory Services in Hong Kong.

Prior to joining Gleneagles, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician in the Department of Medicine in Queen Elizabeth Hospital. In 2009, he took up part-time administrative roles at the Kowloon Central Cluster on top of his clinical duties. During the years between 2012 and 2019, he became a full-time medical administrator at the Hospital Authority Head Office, assuming management roles in various areas including Patient Safety, Strategy & Service Planning, Infection Control and Cluster Services.

Dr Tsang is a Fellow of the Hong Kong Academy of Medicine (Community Medicine), a Fellow of the Hong Kong College of Community Medicine and a Fellow of The Royal Australasian College of Medical Administrators. He is also an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine of The University of Hong Kong.

Hospital Authority, Hong Kong

Dr Christina MAW is currently the Chief Manager (Transformation Services) of HA Head Office, responsible for overseeing the planning, implementation and review of public-private-partnership projects of HA. She is also supporting the Strategic Purchasing Office of the Health Bureau on public-private-partnership initiatives. Dr MAW is a Specialist in Public Health Medicine. Before taking up the current post, Dr MAW was the Hospital Chief Executive of Grantham Hospital & Tung Wah Hospital, and previously working as the Chief Manager in the HA Head Office responsible for the planning and implementation of elderly, rehabilitation services, palliative care and primary care services.

Vice President of Medical Affairs, United Family Healthcare, China

Professor Alastair Mah, Vice President of Medical Affairs at United Family Healthcare, leads all medical staff and clinical services, with clinical governance and academic governance responsibilities. Alastair has extensive hospital management experience in Australia and Hong Kong, including as Chief Medical Officer at major academic health services. He served on multiple Board of Directors, including the Royal Australasian College of Medical Administrators and Rural Workforce Agency of Victoria. He holds
professorial positions with Deakin University, Chinese University of Hong Kong and Hong Kong University.

Patient Liason Advisory Group, Hong Kong

Bill Wang is a 2018 recipient of a combined kidney and liver transplant to treat his polycystic kidney
and liver disease, which was diagnosed two decades earlier. A retired lawyer and corporate
executive, he has been active in patient and carer well-being advocacy, healthcare policy and
regulatory reform and organ donation promotion, assisting pro bono in legal and governance matters
for NGOs, charities and patient groups. Bill chairs the Patient Liaison and Advisory Group of the International Society of Nephrology (ISN). He also serves on the governance bodies of the Hong Kong Kidney Foundation, Hong Kong Transplant Sports Association, and Hong Kong Chartered Governance Institute and the Safety and Quality Committee at Prince of Wales Hospital, Chinese University of Hong Kong. Bill is a keen observer of medical and surgical advancements in the treatment of kidney, liver and other disorders. As a patient and organ transplant recipient, he has the utmost respect for all healthcare professionals and is immensely grateful to organ donors and their families. He has insatiable drive to understand medical concepts, terminologies, physiologies, risk factors and clinical trials to effectively bridge the communication, knowledge and expectation gaps between patients, carer and their providers. Bill has been a sought-after patient voice both locally and internationally in professional journals, conferences, media and advisory bodies. He remains an active and forward-looking volunteer, leveraging his personal and professional experiences to promote healthy lifestyle, disease prevention, early detection and intervention, improved people care, increased social and mental health support and organ donation rate.

Hospital Authority, Hong Kong

Dr. Lui Siu-Fai  BSS, MH, JP
Co-convenor of Local Program Advisory Committee, Hong Kong 2024
Co-convenor of Local Program Advisory Committee, Hong Kong 2105
Adjunct Professor, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong. Hon. Consultant (Quality & Safety), Prince of Wales Hospital, Hospital Authority
Hong Kong Kidney Foundation, Chairman
International Federation of Kidney Foundation, Past-Chairman

Hospital Authority, Hong Kong

Dr. Raymond Cheung is currently the Chief Manager (Patient Safety & Risk Management), Hospital Authority. He has worked as Service Director (Quality & Safety) in Kowloon West Cluster and Deputy Hospital Chief Executive (Quality & Performance) in Princess Margaret Hospital. Dr. Cheung is a specialist in Critical Care Medicine and has completed master degree in Science in Epidemiology and Biostatistics. Over the years, he had led multiple projects related to quality improvement and workflow reengineering at hospital and cluster levels.